FDA approves generic diuretic to treat edemas

The Food and Drug Administration recently approved Edenbridge Pharmaceuticals' ethacrynic acid tablets.

The tablets are a potent diuretic intended for the treatment of edema.

The new treatment represents the first approved generic form of brand-name Edecrin tablets, which are produced by Canada-based Valeant Pharmaceuticals.

Edenbridge Pharmaceuticals, headquartered in Parsippany, N.J., plans to launch the ethacrynic acid tablets as soon as possible.

More articles on the drug market:

Sanofi, U.S. Army partner to speed up Zika vaccine development
Drugmakers hesitant to let generic rival Teva join PhRMA
Viewpoint: How drug coupons keep prices high

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.